Previous Close | 27.90 |
Open | 28.20 |
Bid | 27.60 |
Ask | 28.25 |
Strike | 120.00 |
Expire Date | 2024-12-20 |
Day's Range | 28.20 - 28.20 |
Contract Range | N/A |
Volume | |
Open Interest | 98 |
Eli Lilly may be riding high on its diabetes and weight-loss treatments Mounjaro and Zepbound — which Wall Street estimates could net the company $13.5 billion in 2024 — but the success comes with ongoing criticism about pricing and access.
We recently published a list of 9 Best Stocks to Buy in 2024 According to Billionaire George Soros. Since Novo Nordisk A S (NYSE:NVO) ranks 3rd in the list, it deserves a deeper look. Billionaire George Soros has been one of the most active and divisive figures in the Wall Street. Often a right-wing target, the billionaire […]
These five companies may offer higher earnings and return potential with lower risk. Two Leaderboard stocks included.